Filing Details
- Accession Number:
- 0001415889-23-012331
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-16 19:14:00
- Reporting Period:
- 2023-08-15
- Accepted Time:
- 2023-08-16 19:14:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697433 | Mulham David Mulham | 3838 West Parkway Blvd Salt Lake City UT 84120 | Chief Sales Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-08-15 | 2,159 | $65.34 | 5,448 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Weighted average price $65.3389. Price range in multiple transactions was $65.30 to $65.465 inclusively.
Billionaire Hedge Funds
